Biotectix is developing a new class of bioactive conductive polymer electrodes and coatings for electrodes that result in a fully integrated electrode-tissue interface. A number of benefits are driven by this platform technology including:

These benefits lead to reduced surgical, hardware complications and reduced need for surgery to change batteries. Our technology consists of three major elements including an electrically conductive substrate, a biological component, and a conductive polymer. Biotectix thereby addresses key shortcomings associated with traditional metallic biomedical device electrodes such as steel, platinum, iridium, or gold. These traditional electrodes are energy inefficient, hard, non-biocompatible and can cause local tissue damage and scarring. They also have limited-MRI compatibility, and often don’t function for as long or as well as intended leading to more frequent battery replacement.

Devices that can benefit from the Biotectix invention include pacemakers, cortical probes, cochlear implants, glucose sensors and deep brain stimulators, among others. Drug-eluting stents and modern prosthetic devices are additional applications.